# RYZUMVI
> **NDA217064** · New Drug Application · Sponsor: FAMYGEN LIFE SCI · Approved 2023-09-25
## Drug
- **FDA Application Number:** NDA217064
- **Application type:** New Drug Application
- **Brand name:** RYZUMVI
- **Generic name:** PHENTOLAMINE MESYLATE
- **Active ingredients:** PHENTOLAMINE MESYLATE
- **Dosage form:** SOLUTION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** FAMYGEN LIFE SCI
- **Manufacturer:** Oyster Point Pharma, Inc.
- **First approval:** 2023-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217064)
---
*AI Analytics · CC0 1.0*